Diagnostic and Treatment Approach for Aspergillus Pneumonia

Patient Population and Risk Factors

Aspergillus pneumonia occurs almost exclusively in immunocompromised patients, including neutropenic patients, allogeneic hematopoietic-cell transplant recipients, patients with acute leukemia, solid organ transplant recipients, or those on high-dose corticosteroids, according to the Infectious Diseases Society of America 1, 2

Aspergillus pneumonia presents with persistent fever despite broad-spectrum antibiotics in neutropenic patients, progressive respiratory failure, and potential hemoptysis from vascular invasion, as noted by the Infectious Diseases Society of America 1, 2
Serum galactomannan assay has high sensitivity in neutropenic patients, and bronchoscopy with BAL for galactomannan testing is highly specific, as recommended by the Infectious Diseases Society of America 3, 4

Aspergillus pneumonia shows nodules with halo sign, air-crescent sign, or progressive necrotizing pneumonia on CT imaging, according to the Infectious Diseases Society of America 1, 2
Immediate initiation of antifungal therapy is critical, with voriconazole as the drug of choice based on superior survival and response rates compared to amphotericin B, as recommended by the Infectious Diseases Society of America 1, 2, 4, 6
Therapeutic drug monitoring is mandatory for voriconazole due to variable pharmacokinetics, as noted by the Infectious Diseases Society of America 6
Alternative first-line therapy includes liposomal amphotericin B 3 mg/kg/day IV for patients with voriconazole contraindications or intolerance, as recommended by the European Society for Medical Oncology 1, 2, 7, 6
The treatment duration should be at least 6-12 weeks, continuing throughout the immunosuppression period until complete resolution of clinical and radiographic findings, as recommended by the Infectious Diseases Society of America 1, 2, 6
Salvage therapy, if initial therapy fails, includes switching drug classes to use L-AMB, caspofungin, or posaconazole, as recommended by the Infectious Diseases Society of America 1, 2, 6
In rare cases where a patient has both Aspergillus pneumonia and farmer's lung, treatment requires antifungal therapy for invasive aspergillosis and corticosteroids for hypersensitivity pneumonitis, along with antigen avoidance, as noted by the Infectious Diseases Society of America 8